None listed
Conditions
Brief summary
We have submitted an application the the University of NSW HREC who have requested we proceed with a clinical trial application. The study is being conducted to trial simple strategies to improve the uptake of measles immunisation in adults born in or after 1966 who may not be fully vaccinated and at risk of being infected with measles. The study is a pre-post intervention design. A random sample of 53 general practices will be recruited to participate. During the intervention, the general practices will be given resources to promote vaccination of adults against measles at the same time as these parents attend the medical practice to have their children vaccinated. The campaign is called "Vaccinate the child, vaccinate the parent".
Interventions
The intervention is the promotion to participating practices of screening of parents for practice documentation or history of MMR vaccination whilst they are in the practice to have their young children vaccinated.
For practices who consent to participate, an appointment will be arranged between practice staff and study staff to thoroughly describe the program and provide the study materials.
The following resources will be included in the study materials;
Study protocol
Information and conse
The intervention is the promotion to participating practices of screening of parents for practice documentation or history of MMR vaccination whilst they are in the practice to have their young children vaccinated. For practices who consent to participate, an appointment will be arranged between practice staff and study staff to thoroughly describe the program and provide the study materials. The following resources will be included in the study materials; Study protocol Information and consent forms for participating general practices/nurses Information and consent forms for participating parents, this will include the Priorix product and consumer information Advertising material including a poster and leaflets, vaccine fridge prompts. Promotional reminders for recruited practices Pre-vaccination screening checklist Visual prompts (poster and leaflets) will be available in the waiting room to promote participation. Fridge magnets will be placed on the vaccine fridge to prompt providers The intervention will last for 6 months The promotional reminders will be a contact presence throughout teh waiting room and on the vaccine fridge for the duration of the intervention.
Sponsors
GlaxoSmithKline pharmaceuticals
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to 47 Years
Healthy volunteers
Yes
Inclusion criteria
Inclusion criteria for general practices (“primary participants”): all general practices in South Eastern Sydney Local Health District with a vaccine account number (from the State Vaccine Centre) Inclusion criteria for participants indirectly included in the research (“secondary participants”): Adults born in or after 1966 who attend the practice with a child for scheduled childhood vaccinations will be approached by the GP or practice nurse to participate.
Exclusion criteria
Exclusion criteria for general practices (“primary participants”): general practices in South Eastern Sydney Local Health District that do not have a vaccine account number. Exclusion criteria for participants indirectly included in the research (“secondary participants”): 1. Adults born prior to 1966 who attend the practice with a child for routine childhood vaccinations. 2. Adults unaccompanied by a child presenting for treatment or vaccination. 3. Participants are not required to be immunised to be included in the study. Any participants who are pregnant, immunocompromised, symptomatic HIV positive, immunocompromised, allergic to any components in the vaccine will not be vaccinated, but a questionnaire will still be completed and the medical practice paid for its return. The participant’s information form will contain information on the contraindications for vaccination. The vaccine provider will also assess for contraindications as part of the NHMRC recommended routine pre vaccination assessment for all vaccinations (page 16, Australian Immunisation Handbook) 4. Adults declining consent. Note, adult born on or after 1966 that decline participation in the study can still receive Priorix vaccine if they are not immune, have an uncertain or no vaccination history.
Outcome results
None listed